Caremarque Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.29%
- Profit Growth 163.25%
- Ebitda 78.04%
- Net Worth 128.07%
- Total Assets 21.39%
About Caremarque Diagnostics
Caremarque Diagnostics Private Limited (CDPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 2019 (Six years 18 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2019PTC319578
-
Company No.
319578
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jan 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Caremarque Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Khan
|
Director | 15-Jan-2019 | Current |
|
Sadruddin Khan
|
Director | 15-Jan-2019 | Current |
Financial Performance of Caremarque Diagnostics.
Caremarque Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.29% increase. The company also saw a substantial improvement in profitability, with a 163.25% increase in profit. The company's net worth Soared by an impressive increase of 128.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caremarque Diagnostics?
In 2021, Caremarque Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
F S Food Products Private LimitedSadruddin Khan is a mutual person
-
Amazon Cattle' S Private Limited
Sadruddin Khan is a mutual person
-
F S Chemicals Private Limited
Sadruddin Khan is a mutual person
-
Fsk Chemicals Private Limited
Sadruddin Khan is a mutual person
-
Fsk Builders And Developers Private Limited
Sadruddin Khan is a mutual person
-
Fsk Traders Private Limited
Sadruddin Khan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caremarque Diagnostics?
Unlock and access historical data on people associated with Caremarque Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caremarque Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caremarque Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
